Vanguard Capital Wealth Advisors Lowers Position in Bristol-Myers Squibb (NYSE:BMY)
Vanguard Capital Wealth Advisors trimmed its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 23.1% in the second quarter, Holdings Channel.com reports. The firm owned 4,000 shares of the biopharmaceutical company’s stock after selling 1,200 shares during the quarter. Vanguard Capital Wealth Advisors’ holdings in Bristol-Myers Squibb were worth $256,000 at the end of […]